Literature DB >> 11731438

Aberrations in the fragile histidine triad (FHIT) gene in idiopathic pulmonary fibrosis.

K Uematsu1, A Yoshimura, A Gemma, H Mochimaru, Y Hosoya, S Kunugi, K Matsuda, M Seike, F Kurimoto, K Takenaka, K Koizumi, Y Fukuda, S Tanaka, K Chin, D M Jablons, S Kudoh.   

Abstract

Idiopathic pulmonary fibrosis (IPF) seems to be closely associated with lung carcinogenesis. To identify the genetic characteristics of precancerous IPF lesions in the peripheral lung, we performed PCR-based microsatellite analysis with DNA extracted from microdissected tissues; fluorescent in situ hybridization (FISH) analysis of the fragile histidine triad (FHIT) gene and immunohistochemical analysis of Fhit protein expression in samples of metaplasias and bronchiolar epithelia obtained from patients with IPF. We used four microsatellite markers of the FHIT gene within or flanking the FHIT gene on chromosome 3p for loss of heterozygosity (LOH) analysis. LOH of the FHIT locus was frequently found among the lesions of metaplasias and bronchiolar epithelia in the patients with IPF [62 (52%) of 119 informative lesions]. Fifty-four (73%) of the 74 lesions of metaplasias and bronchiolar epithelia obtained from the IPF patients with lung carcinoma and 8 (17%) of the 46 samples obtained from the IPF patients without lung carcinoma showed LOH at the FHIT gene (P < 0.0001). We confirmed allelic loss in the metaplasias and bronchiolar epithelia of IPF by FISH analysis of the FHIT gene. Additionally, the level of Fhit protein expression in the metaplastic cells of IPF was frequently reduced. Our findings suggest that allelic loss of the FHIT gene may be involved in carcinogenesis in the peripheral lung of patients with IPF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11731438

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.

Authors:  Keiko Mizuno; Hiroko Mataki; Naohiko Seki; Tomohiro Kumamoto; Kazuto Kamikawaji; Hiromasa Inoue
Journal:  J Hum Genet       Date:  2016-08-04       Impact factor: 3.172

Review 2.  Angiogenesis in interstitial lung diseases: a pathogenetic hallmark or a bystander?

Authors:  Argyris Tzouvelekis; Stavros Anevlavis; Demosthenes Bouros
Journal:  Respir Res       Date:  2006-05-25

3.  Idiopathic pulmonary fibrosis and cancer: do they really look similar?

Authors:  Carlo Vancheri
Journal:  BMC Med       Date:  2015-09-24       Impact factor: 8.775

4.  Pulmonary adenocarcinoma mutation profile in smokers with smoking-related interstitial fibrosis.

Authors:  Andrea Primiani; Dora Dias-Santagata; A John Iafrate; Richard L Kradin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-05-24

Review 5.  Measuring Surgery Outcomes of Lung Cancer Patients with Concomitant Pulmonary Fibrosis: A Review of the Literature.

Authors:  Taichiro Goto
Journal:  Cancers (Basel)       Date:  2018-07-04       Impact factor: 6.639

6.  Lung cancer and interstitial lung diseases: a systematic review.

Authors:  Kostas Archontogeorgis; Paschalis Steiropoulos; Argyris Tzouvelekis; Evangelia Nena; Demosthenes Bouros
Journal:  Pulm Med       Date:  2012-07-29

Review 7.  Idiopathic Pulmonary Fibrosis: Diagnosis and Clinical Manifestations.

Authors:  Yutaro Nakamura; Takafumi Suda
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2016-09-06

Review 8.  Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets.

Authors:  Beatriz Ballester; Javier Milara; Julio Cortijo
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

9.  Lung cancer in patients with and without rheumatoid arthritis: A propensity score-matched survival analysis cohort study.

Authors:  Lei Zhang; Qiliang Zhao; Fan Yuan; Min Liu
Journal:  Thorac Cancer       Date:  2020-03-27       Impact factor: 3.500

Review 10.  Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape?

Authors:  Sara Lettieri; Tiberio Oggionni; Andrea Lancia; Chandra Bortolotto; Giulia Maria Stella
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.